Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The spread ...
Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...
A UCLA-developed nanoparticle is aiming to reprogram the liver in humans to attack pancreatic cancer with an mRNA vaccine (curved, hatched red lines) and an immune-activating fragment of genetic ...
Autonomix's targeted ablation therapy improved symptoms, functionality, and quality of life in severe pancreatic cancer patients, especially those with stage 4 disease. Rapid pain relief and durable ...
A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body. Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs ...
Surufatinib combined with TAS-102 as a late-line therapy in patients with metastatic pancreatic cancer (mPDAC): Updated results of a single-arm, phase II trial. Interim analysis of feasibility, safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback